EUVIMEDEUVIMED entdecken
Open Access

Incorporation of 53BP1 into phase-separated bodies in cancer cells during aberrant mitosis

Marina Bleiler iD, Aiyana Cyr, Dennis L Wright, Charles Giardina

Journal of Cell Science · 2023

DOI: 10.1242/jcs.260027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cell Science, 2023. Verfasst von Marina Bleiler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cell Biology, University of Connecticut, Storrs, CT 06269, USA. Hauptthemen laut MEDLINE: DNA Repair, Neoplasms, Tumor Suppressor p53-Binding Protein 1. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

53BP1 (also known as TP53BP1) is a key mediator of the non-homologous end joining (NHEJ) DNA repair pathway, which is the primary repair pathway in interphase cells. However, the mitotic functions of 53BP1 are less well understood. Here, we describe 53BP1 mitotic stress bodies (MSBs) formed in cancer cell lines in response to delayed mitosis. These bodies displayed liquid–liquid phase separation characteristics, were close to centromeres, and included lamin A/C and the DNA repair protein RIF1. After release from mitotic arrest, 53BP1 MSBs decreased in number and moved away from the chromatin. Using GFP fusion constructs, we found that the 53BP1 oligomerization domain region was required for MSB formation, and that inclusion of the 53BP1 N terminus increased MSB size. Exogenous expression of 53BP1 did not increase MSB size or number but did increase levels of MSB-free 53BP1. This was associated with slower mitotic progression, elevated levels of DNA damage and increased apoptosis, which is consistent with MSBs suppressing a mitotic surveillance by 53BP1 through sequestration. The 53BP1 MSBs, which were also found spontaneously in a subset of normally dividing cancer cells but not in non-transformed cells (ARPE-19), might facilitate the survival of cancer cells following aberrant mitoses. This article has an associated First Person interview with the first author of the paper.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA RepairNeoplasmsTumor Suppressor p53-Binding Protein 1HumansChromatinDNA DamageDNA End-Joining RepairMitosisCell Line, Tumor

Stichwörter der Autor:innen

53BP1ARPE-19Colon cancer cell linesLamin A/CMitotic arrestMitotic stressRIF1

Substanzen

ChromatinTumor Suppressor p53-Binding Protein 1TP53BP1 protein, human

Autor:innen und Institutionen

  • Department of Molecular and Cell Biology, University of Connecticut, Storrs, CT 06269, USA.
  • Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269, USA.

ORCID-Profile: Marina Bleiler

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Bleiler, M., Cyr, A., Wright, D. L., & Giardina, C. (2023). Incorporation of 53BP1 into phase-separated bodies in cancer cells during aberrant mitosis. Journal of Cell Science. https://doi.org/10.1242/jcs.260027

Vancouver

Bleiler M, Cyr A, Wright DL, Giardina C. Incorporation of 53BP1 into phase-separated bodies in cancer cells during aberrant mitosis. Journal of Cell Science. 2023. doi:10.1242/jcs.260027

BibTeX
@article{Bleiler2023,
  author = {Bleiler, Marina and Cyr, Aiyana and Wright, Dennis L and Giardina, Charles},
  title = {Incorporation of 53BP1 into phase-separated bodies in cancer cells during aberrant mitosis},
  journal = {Journal of Cell Science},
  year = {2023},
  doi = {10.1242/jcs.260027}
}
Kostenlos starten →